We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
348 result(s) found, displaying 281 to 290
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 100/1000 sitagliptin(as phosphate monohydrate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 50/500 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/500 mg extended release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 50/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DIFICID fidaxomicin 200 mg tablets in bottles.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Pembrolizumab (rch)
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for M-M-R II powder for injection vial with pre-filled diluent syringe, single dose.